|
1. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal
squamous cancers. CA Cancer J Clin 1995; 45: 328-351.
2. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic
inflammation is B lymphocyte dependent. Cancer Cell 2005; 7(5):411-23.
3. Kumar, V, Abbas, A.K., Fausto, N. Robbins and Cotran Pathologic Basis of Disease, 7th
ed. 2005;Ch. 16; 773-795.
4. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, Teronen O. Survival after
diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg. 2008; 46: 187-191.
5. Taiwan area main causes of death 2008, Department of Health, The executive Yuan,
Taiwan, R.O.C., 2009.
6. Genomic imbalances in precancerous tissues signal oral cancer risk. Garnis C, Chari R,
Buys TP, Zhang L, Ng RT, Rosin MP, Lam WL. Mol Cancer 2009; 23;8:50.
7. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. Engl J Med 2001;
26;344(17):1323-6.
8. Batsakis JG, Suarez P, el-Naggar AK. Proliferative verrucous leukoplakia and its related
lesions. Oral Oncol 1999; 35(4):354-9.
9. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia
classification systems: predictive value, utility, weaknesses and scope for improvement.
J Oral Pathol Med 2008; 37(3):127-33.
10. Reibel J. Prognosis of oral premalignant lesions: significance of clinical,
histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;
14: 47-62.
11. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol
2001; 194: 294-7.
12. Warnakulasuriya S, Johnson NW, Van der Wall I. Nomenclature and classification of
potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36:
27
575-580.
13. Squier CA. The permeability of oral mucosa. Crit Rev Oral Biol Med 1991;2(1):13-32.
14. Dale BA, Salonen J, Jones AH. New approaches and concepts in the study of
differentiation of oral epithelia. Crit Rev Oral Biol Med 1990;1(3):167-90.
15. World Health Organization Classification of Tumours. Pathology & genetics. Head and
neck tumours. International Agency for Research on Cancer (IARC). In: Barnes L,
Eveson JW, Reichart P, Sidransky D, eds. Head and neck tumors. Lyon: IARC Press,
2005; 177–80.
16. Warnakulasuriya KAAS, MacDonald DG. Epithelial cell kinetics in oral leukoplakia. J
Oral Pathol Med 1995; 24: 165–9.
17. Pindborg JJ, Reichart P, Smith CJ, Van der Waal I. World Health Organization:
histological typing of cancer and precancer of the oral mucosa. Berlin: Springer-Verlag,
1997.
18. Bouquot J, Speight PM, Farthing PM. Epithelial Dysplasia of the Oral Mucosa –
diagnostic problems and prognostic features. Current Diagnostic Pathology 2006; 12:
11-22
19. Brothwell DJ, Lewis DW, Bradley G, Leong I, Jordan RC, Mock D, Leake JL.
Observeragreement in the grading of oral epithelial dysplasia. Community Dent Oral
Epidemiol 2003; 31:300-5
20. Ilagan MX, Kopan R. SnapShot: notch signaling pathway. Cell 2007; 23;128(6):1246.
21. Artavanis-Tsakonas S, Matsuno K, Fortini ME. Notch signaling. Science 1995; 14;
268(5208): 225-32. Review.
22. Kimble J, Simpson P. The LIN-12/Notch signaling pathway and its regulation. Annu Rev
Cell Dev Biol 1997; 13:333-61.
23. Fiúza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol 2007; 194(3):
459-74.
28
24. Morgan T. The theory of the gene. Am Nat 1917; 51:513–44.
25. Fehon RG, Kooh PJ, Rebay I, Regan CL, Xu T, Muskavitch MA & Artavanis-Tsakonas
S 1990 Molecular interactions between the protein products of the neurogenic loci Notch
and Delta, two EGF-homologous genes in Drosophila. Cell 61 523–534.
26. Artavanis-Tsakonas S, Simpson P. Choosing a cell fate: a view from the Notch locus.
Trends Genet. 1991;7(11-12):403-8. Review.
27. Campos-Ortega JA. Genetic mechanisms of early neurogenesis in Drosophila
melanogaster. J Physiol Paris 1994;88(2):111-22.
28. Artavanis-Tsakonas S, Delidakis C, Fehon RG. The Notch locus and the cell biology of
neuroblast segregation. Annu Rev Cell Biol 1991;7:427-52.
29. Palomero T, Ferrando A. Therapeutic targeting of NOTCH1 signaling in T-cell acute
lymphoblastic leukemia. Clin Lymphoma Myeloma 2009; 9 Suppl 3:S205-10. Review.
30. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G, Krishna S. Notch1
regulates the functional contribution of RhoC to cervical carcinoma progression. Br J
Cancer 2010; 5;102(1):196-205.
31. Katoh M, Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol 2007;
30(1):247-51. Review.
32. Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: a
member of the notch gene family transforms mammary epithelial cells. J Virol 1992;
66(4):2594-9.
33. Boyer-Di Ponio J, Wright-Crosnier C, Groyer-Picard MT, Driancourt C, Beau I,
Hadchouel M, Meunier-Rotival M. Biological function of mutant forms of JAGGED1
proteins in Alagille syndrome: inhibitory effect on Notch signaling. Hum Mol Genet
2007; 16(22):2683-92.
29
34. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S,
Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA,
Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3
mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.
Nature 1996;383(6602):707-10.
35. Turnpenny PD, Whittock N, Duncan J, Dunwoodie S, Kusumi K, Ellard S. Novel
mutations in DLL3, a somitogenesis gene encoding a ligand for the Notch signalling
pathway, cause a consistent pattern of abnormal vertebral segmentation in
spondylocostal dysostosis. J Med Genet 2003; 40(5):333-9.
36. Arboleda-Velasquez JF, Zhou Z, Shin HK, Louvi A, Kim HH, Savitz SI, Liao JK,
Salomone S, Ayata C, Moskowitz MA, Artavanis-Tsakonas S. Linking Notch signaling
to ischemic stroke. Proc Natl Acad Sci U S A 2008; 105(12):4856-61.
37. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the
human homolog of the Drosophila notch gene, is broken by chromosomal translocations
in T lymphoblastic neoplasms. Cell 1991; 23;66(4):649-61.
38. Yochem J, Weston K & Greenwald I. The Caenorhabditis elegans lin-12 gene encodes a
transmembrane protein with overall similarity to Drosophila Notch. Nature 1988; 335;
547–550.
39. Lubman OY, Korolev SV, Kopan R. Anchoring notch genetics and biochemistry;
structural analysis of the ankyrin domain sheds light on existing data. Mol Cell 2004;
12;13(5):619-26.
40. Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologue mouse Notch 3 lacks
specific epidermal growth factor-repeats and is expressed in proliferating
neuroepithelium. Mech Dev 1994;46(2):123-36.
30
41. Bigas A, Martin DI, Milner LA. Notch1 and Notch2 inhibit myeloid differentiation in
response to different cytokines. Mol Cell Biol 1998;18(4):2324-33.
42. Roehl H, Bosenberg M, Blelloch R, Kimble J. Roles of the RAM and ANK domains in
signaling by the C. elegans GLP-1 receptor. EMBO J 1996; 15(24):7002-12.
43. Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue
microarray - a high-throughput molecular analysis in head and neck cancer. J Oral
Pathol Med 2008;37(3):166-76. Review.
44. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high throughput
molecular profiling of tumor specimens. Nat Med 1998; 4: 844–7.
45. Battifora H. The multitumor (sausage) tissue block: Novel method for
immunohistochemical antibody testing. Lab Invest 1986; 55: 244–8.
46. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for
high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10: 657–62.
47. D''Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene
2008;27(38):5148-67. Review.
48. Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet
2007; 17(1):52-9. Review
49. Panelos J, Tarantini F, Paglierani M, Di Serio C, Maio V, Pellerito S, Pimpinelli N,
Santucci M, Massi D. Photoexposition discriminates Notch 1 expression in human
cutaneous squamous cell carcinoma. Mod Patho. 2008; 21(3):316-25.
50. Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease.
Semin Cancer Biol 2004; 14(5):320-8. Review.
51. Lowell S, Jones P, Le Roux I, Dunne J, Watt FM. Stimulation of human epidermal
differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr Biol
31
2000;10:491–500.
52. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, et al. Notch1 functions
as a tumor suppressor in mouse skin. Nat Genet 2003; 33:416–21.
53. Hijioka H, Setoguchi T, Miyawaki A, Gao H, Ishida T, Komiya S, Nakamura N.
Upregulation of Notch pathway molecules in oral squamous cell carcinoma. Int J Oncol
2010; 36(4):817-22
54. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, et al. Notch
signaling is a direct determinant of keratinocyte growth arrest and entry into
differentiation. EMBO J 2001;20:3427-36.
55. Lin JT, Chen MK, Yeh KT, Chang CS, Chang TH, Lin CY, Wu YC, Su BW, Lee KD,
Chang PJ. Association of High Levels of Jagged-1 and Notch-1 Expression with Poor
Prognosis in Head and Neck Cancer. Ann Surg Oncol 2010 Jun 2.
|